Rate and Risk Factors Associated With Prolonged Opioid Use After Surgery: A Systematic Review and Meta-analysis by Lawal, Oluwadolapo D. et al.
University of Rhode Island 
DigitalCommons@URI 
Pharmacy Practice Faculty Publications Pharmacy Practice 
2020 
Rate and Risk Factors Associated With Prolonged Opioid Use 
After Surgery: A Systematic Review and Meta-analysis 
Oluwadolapo D. Lawal 
University of Rhode Island 
Justin Gold 
University of Rhode Island 
Amala Murthy 
University of Rhode Island 
Rupam Ruchi 
Egle Bavry 
See next page for additional authors 
Follow this and additional works at: https://digitalcommons.uri.edu/php_facpubs 
Citation/Publisher Attribution 
Lawal, O. D., Gold, J., Murthy, A., Ruchi, R., Bavry, E., Hume, A. L.,...Wen, X. (2020). Rate and Risk Factors 
Associated With Prolonged Opioid Use After Surgery: A Systematic Review and Meta-analysis. JAMA 
Network Open, 3(6), e207367. doi: 10.1001/jamanetworkopen.2020.7367 
Available at: http://dx.doi.org/10.1001/jamanetworkopen.2020.7367 
This Article is brought to you for free and open access by the Pharmacy Practice at DigitalCommons@URI. It has 
been accepted for inclusion in Pharmacy Practice Faculty Publications by an authorized administrator of 
DigitalCommons@URI. For more information, please contact digitalcommons@etal.uri.edu. 
Authors 
Oluwadolapo D. Lawal, Justin Gold, Amala Murthy, Rupam Ruchi, Egle Bavry, Anne L. Hume, Todd 
Brothers, and Xuerong Wen 
This article is available at DigitalCommons@URI: https://digitalcommons.uri.edu/php_facpubs/174 
Original Investigation | Surgery
Rate and Risk Factors Associated With Prolonged Opioid Use After Surgery
A Systematic Review and Meta-analysis
Oluwadolapo D. Lawal, MPH; Justin Gold, BS; Amala Murthy, PharmD; Rupam Ruchi, MD; Egle Bavry, MD; Anne L. Hume, PharmD; Adam K. Lewkowitz, MD;
Todd Brothers, PharmD; Xuerong Wen, PhD, MPH, MS
Abstract
IMPORTANCE Prolonged opioid use after surgery may be associated with opioid dependency and
increased health care use. However, published studies have reported varying estimates of the
magnitude of prolonged opioid use and risk factors associated with the transition of patients to long-
term opioid use.
OBJECTIVES To evaluate the rate and characteristics of patient-level risk factors associated with
increased risk of prolonged use of opioids after surgery.
DATA SOURCES For this systematic review and meta-analysis, a search of MEDLINE, Embase, and
Google Scholar from inception to August 30, 2017, was performed, with an updated search
performed on June 30, 2019. Key words may include opioid analgesics, general surgery, surgical
procedures, persistent opioid use, and postoperative pain.
STUDY SELECTION Of 7534 articles reviewed, 33 studies were included. Studies were included if
they involved participants 18 years or older, evaluated opioid use 3 or more months after surgery, and
reported the rate and adjusted risk factors associated with prolonged opioid use after surgery.
DATA EXTRACTION AND SYNTHESIS The Meta-analysis of Observational Studies in Epidemiology
(MOOSE) and Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA)
reporting guidelines were followed. Two reviewers independently assessed and extracted the
relevant data.
MAIN OUTCOMES AND MEASURES The weighted pooled rate and odds ratios (ORs) of risk factors
were calculated using the random-effects model.
RESULTS The 33 studies included 1 922 743 individuals, with 1 854 006 (96.4%) from the US. In
studies with available sex and age information, participants were mostly female (1 031 399; 82.7%)
and had a mean (SD) age of 59.3 (12.8) years. The pooled rate of prolonged opioid use after surgery
was 6.7% (95% CI, 4.5%-9.8%) but decreased to 1.2% (95% CI, 0.4%-3.9%) in restricted analyses
involving only opioid-naive participants at baseline. The risk factors with the strongest associations
with prolonged opioid use included preoperative use of opioids (OR, 5.32; 95% CI, 2.94-9.64) or illicit
cocaine (OR, 4.34; 95% CI, 1.50-12.58) and a preoperative diagnosis of back pain (OR, 2.05; 95% CI,
1.63-2.58). No significant differences were observed with various study-level factors, including a
comparison of major vs minor surgical procedures (pooled rate: 7.0%; 95% CI, 4.9%-9.9% vs 11.1%;
95% CI, 6.0%-19.4%; P = .20). Across all of our analyses, there was substantial variability because of
heterogeneity instead of sampling error.
(continued)
Key Points
Question What are the rate and risk
factors associated with prolonged use of
opioid medications after surgery?
Findings In this systematic review and
meta-analysis of 33 observational
studies including more than 1.9 million
patients, 7% of patients continued to fill
opioid prescriptions more than 3
months after surgery. Preoperative use
of opioids, illicit cocaine use, and pain
conditions before surgery had the
strongest associations with prolonged
opioid use after surgery.
Meaning The findings suggest that an
evaluation of opioid use among patients
before surgery and modification of
patient-level risk factors when possible
may be included as part of a
comprehensive strategy to reduce the
risk of prolonged opioid use
after surgery.
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Abstract (continued)
CONCLUSIONS AND RELEVANCE The findings suggest that prolonged opioid use after surgery may
be a substantial burden to public health. It appears that strategies, such as proactively screening for
at-risk individuals, should be prioritized.
JAMA Network Open. 2020;3(6):e207367. doi:10.1001/jamanetworkopen.2020.7367
Introduction
The misuse, overdose, and abuse of prescription opioids constitute sources of substantial morbidity
and mortality in the US and globally.1-5 Approximately 130 individuals in the US die each day of opioid
overdose, with one of the largest proportion of preventable deaths in the US being attributable to
opioid-related deaths.3 In addition to the substantial mortality burden, prescription opioid misuse,
abuse, dependence, and overdose were reported to cost the US health care system an estimated
$78.5 billion in 2013.6 Increases in prescription opioid use and incidence of opioid-related deaths
have also been reported globally, including in European countries and Canada.4,5,7-9
Many of the efforts to curb the opioid crisis in the US have focused on regulatory changes
regarding opioid use for chronic, noncancer pain, with the guidance for postoperative opioid
analgesia use being less clear.10-12 The medical literature12,13 purports that inappropriate opioid
prescribing for peri- and postoperative analgesia in the form of inadequate or excessive dispensing
may contribute to the ongoing epidemic. Of note, opioids remain the standard of care for treatment
of acute and routine postoperative pain,14,15 and surgical procedures remain the primary reason for
exposure to these medications.12,16 There is also substantial variation in opioid prescribing among
clinicians, particularly in the quantities and dosages of opioids after common general surgical
procedures.17,18 This variation is further complicated with the potential for misuse and diversion, with
67% to 92% of all opioids prescribed for postoperative pain remaining unused.19
The association between opioid prescribing after surgery and the opioid crisis is complex.
Inadequate postoperative pain management, including using opioids, has been reported to be
associated with increased risk for chronic pain, thus warranting the need for long-term opioid
use.20-25 Conversely, the receipt of prescription opioids after surgery is suggested to be associated
with increased risk for chronic opioid use. In a retrospective analysis of population-based claims data
from Canada,26 individuals prescribed opioids within 7 days of a low-risk surgical procedure were
44% more likely to become prolonged opioid users within 1 year after surgery compared with
individuals who did not receive these medications. Lastly, undergoing a surgical procedure has been
hypothesized as an independent risk factor for prolonged opioid use after surgery.11,12,27-29
Although several studies have sought to quantify the rate of and characterize risk factors for
prolonged opioid use after surgery, the extent and strength of association have been inconsistent.
Despite using similar definitions of prolonged opioid use and eligibility criteria, studies30-32 enrolling
opioid-naive patients undergoing major surgical procedures in the US reported incidence rates
ranging from 0.5% to 13.0%. Incidence rates as high as 44% for 1 year after surgery have also been
reported.33,34 To address these conflicting results and to account for potential bias related to
differences in study-level factors and low sample sizes, we performed a meta-analysis of published
literature to systematically characterize and aggregate the magnitude and patient-level risk factors
associated with increased risk of prolonged opioid use after surgery.
Methods
This systematic review and meta-analysis was conducted according to the Meta-analysis of
Observational Studies in Epidemiology (MOOSE) and Preferred Reporting Items for Systematic Reviews
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and Meta-analyses (PRISMA) reporting guidelines.35,36 The study protocol is available in the PROSPERO
database (CRD42019129239).
Literature Search
Relevant studies were identified through an initial literature search of MEDLINE, Embase, and Google
Scholar from inception of these databases to August 30, 2017, with an updated search performed on
June 30, 2019. Eligible studies were identified from electronic databases using search terms and
keywords such as opioid analgesics, general surgery, surgical procedures, persistent opioid use, and
postoperative pain. The full search strategy is available in the eAppendix in the Supplement. We also
searched bibliographies of relevant articles to identify additional eligible publications.
Study Selection
Two of us (J.G. and A.M.) independently assessed all titles and abstracts of studies to determine
studies eligible for full-text review. Eligible studies were restricted to published observational studies
evaluating opioid use after surgery. Studies were included if they (1) were published in the English
language; (2) enrolled participants 18 years or older; (3) included a minimum of 50 patients; (4)
involved a noninjectable opioid prescription fill at least 3 months after the index surgical procedure;
and (5) reported the rate and adjusted outcome estimates for patient-level risk factors associated
with prolonged opioid use after surgery. Given differences with opioid use in cancer vs noncancer
pain management, we excluded studies evaluating cancer pain. In addition, eligible studies needed to
have accounted for opioids dispensed in the perioperative period or to have incorporated a lag period
for at least 1 month after the index surgical procedure. This criterion was included to account for
opioids prescribed as part of routine management of postoperative pain before assessing prolonged
opioid use after surgery.
Currently, there is not an accepted definition of prolonged opioid use in the medical literature.
Therefore, all studies that met the inclusion criteria were considered regardless of variations in the
operational definition of prolonged opioid use within and among studies. However, because opioids
are often prescribed preemptively to manage peri- or postoperative pain during the few days or
months, in some instances, after surgery, we set a 3-month threshold after the index surgical
procedure before assessing prolonged opioid use. As such, prolonged opioid use in this study refers
to any opioid use pattern reported by the included studies occurring at least 3 months after surgery.
An exception is use of the term chronic opioid use. Based on previous literature,2,11,37-40 we defined
chronic opioid use as the receipt of at least 10 opioid prescription fills, at least 90 consecutive days’
supply of opioids, or 120 cumulative days in the first year after surgery, excluding the initial 90
postoperative days. Because we expected substantial between-study variation in prolonged opioid
use definitions, in sensitivity analyses, we repeated our primary analysis to assess the pooled rate of
prolonged opioid use by aggregating evidence across studies involving comparable definitions for
opioid use after surgery (eTable 1 in the Supplement).
Data Extraction
Data extraction was performed by the same 2 reviewers (J.G. and A.M.) from the literature search
using structured forms. A third reviewer (O.D.L.) assessed the data extraction forms for
completeness and accuracy. Extracted information from eligible studies included the study design,
sample size, length of follow-up, types of surgical procedure, proportions of opioid-naive and opioid-
experienced individuals at baseline, and the definitions of prolonged opioid use after surgery. In
addition, rates and adjusted estimates associated with the longest follow-up time were extracted. We
did not contact authors for information missing from published texts.
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Quality Assessment
The quality of included studies was assessed by 2 independent reviewers (O.D.L. and J.G.) using the
Newcastle-Ottawa Scale,41 and disagreements were resolved by discussion. Studies with a
Newcastle-Ottawa Scale score greater than 7 were considered to be high in quality.
Statistical Analysis
The primary outcomes of interest were the pooled rate and magnitude for individual risk factors of
prolonged opioid use after surgery. No restrictions were made in the type of effect estimates
extracted; therefore, studies reporting odds ratios (ORs), risk ratios, or hazard ratios were eligible for
inclusion. Based on the overall low prevalence of the risk factors in the individual studies (ie, <10%),
we regarded risk ratios and ORs as equivalent risk measures. However, we pooled studies reporting
hazard ratios in a separate analysis. We calculated the pooled rate of prolonged opioid use after
surgery weighted by the sample size of each eligible study. When 2 or more studies reported adjusted
estimates for the same risk factor, a pooled OR and the corresponding 95% CI were estimated using
the inverse variance method with a random-effects model.42 Based on an a priori assumption of
substantial between-study variation, we prespecified to use the random-effects model for all meta-
analyses. Between-study heterogeneity was tested using the Cochran Q statistic43 and quantified by
the I2 value.44 We considered heterogeneity to be significant at P < .10 and I2>50% to indicate
substantial between-study variation that was beyond chance.45 Heterogeneity was further assessed
in sensitivity analyses. Small-study effect, commonly referred to as publication bias, was examined
using a funnel plot and the Egger regression test. Except for heterogeneity, statistical significance
was set at P < .05; all tests were 2-sided. Statistical analyses were conducted using Comprehensive
Meta-Analysis Software, version 3.0 (Biostat).
We performed additional analyses to evaluate the potential sources of heterogeneity and
robustness of the primary findings. First, we restricted our analyses to studies enrolling only opioid-
naive patients before surgery. We accepted definitions of opioid naive from each eligible study. The
definitions of opioid naivety in studies enrolling only opioid-naive participants are presented in
eTable 2 in the Supplement. Second, we examined whether the rate of prolonged opioid use after
surgery differed by source population or insurance plan, follow-up period (6 months vs >6
months), type of surgery (major vs minor surgery and orthopedic vs nonorthopedic surgery), and
studies conducted in the US vs non-US countries to assess whether our main finding was moderated
by potential differences in prescribing patterns across countries. Classification of major or minor
surgery was based on previously published reports11,12,46 and expert opinion (E.B.) (eTable 3 in the
Supplement). We then aggregated evidence across studies involving comparable definitions for
chronic or prolonged opioid use after surgery. Lastly, for each risk factor reported by at least 3
studies, we recalculated the pooled effect by omitting 1 study at a time. This leave-one-out analysis
was performed to determine the influence of an individual study on the pooled effects.
Results
Study Selection
The search of electronic databases yielded 7534 citations. After removal of duplicates and full-text
reviews, a total of 33 studies involving 1 922 743 individuals, with 1 854 006 (96.4%) from the
US.11,12,16,27,29-33,46-69 The PRISMA diagram is shown in Figure 1.
Study Characteristics
Characteristics of the eligible studies are presented in Table 1. Sample sizes of included studies
ranged from 109 to 675 527 participants. The included studies were conducted in Australia, Canada,
Denmark, France, the US, and the UK, with 26 (78.8%) from the US. Of the 1 247 216 individuals
enrolled in 32 studies with sex information,11,12,16,27,29-33,46,48-69 1 031 399 (82.7%) were females.
Information on age was available in 22 studies11,12,27,29,30,33,48,50,53,54,58-60,62-69; the mean (SD) age
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of participants was 59.3 (12.8) years. The minimum age of participants was 39.0 years and the
maximum age was 80.0 years. Of the 33 studies, 14 (42.4%) involved data from commercial
insurance plans, 12 (36.4%) used hospital institution data, 5 (15.2%) involved military or veterans’
insurance plans, and the remaining 2 (6.1%) were based on data from national, publicly funded health
care systems. Eight studies (24.2%) enrolled only opioid-naive participants,11,12,16,30-32,46,50 18
(54.5%) enrolled both opioid-naive and opioid-experienced participants,27,29,33,48,49,51,52,55-61,66,70
and the remaining 7 studies lacked sufficient information to categorize participants.47,53,54,62-65 The
definitions of long-term, persistent, and prolonged opioid use and opioid naivety varied across studies
(Table 1, and eTables 1-2 in the Supplement). Subgroup analysis based on quality was not performed
because the individual summed score from the Newcastle-Ottawa-Scale varied between 7 and 9,
suggesting that all included studies were high quality.
Primary Outcomes
Across the 33 eligible studies based on random-effects analysis, the pooled rate of prolonged opioid
use after surgery was 6.7% (95% CI, 4.5%-9.8%) (Figure 2), with substantial between-study
heterogeneity (P < .001; I2 = 99.96%).
With the exception of anxiety, we were unable to find comparable risk factors across the 2
studies50,55 that used hazard ratios. Therefore, our analyses on risk factors for prolonged opioid use
were derived from studies reporting risk ratios or ORs.
Significantly increased risks were observed among females compared with males (OR, 1.16; 95%
CI, 1.08-1.25) and among individuals with a high school degree vs a college degree or higher (OR, 1.20;
95% CI, 1.04-1.37) (Table 2).
Increased risk of prolonged opioid use was associated with use of antidepressants, opioids,
benzodiazepines, alcohol, cocaine, or tobacco before surgery (Table 2). Preoperative use of opioids
(OR, 5.32; 95% CI, 2.94-9.64), tobacco (OR, 1.55; 95% CI, 1.23-1.96), or cocaine (OR, 4.34; 95% CI,
1.50-12.58) were identified as having the strongest associations with prolonged use of opioids
after surgery.
Medical comorbidities were differentiated into 3 specific categories: psychological, pain-
associated conditions, and a broader category composed of disorders such as diabetes, pulmonary
disease, and obesity (Table 2). When evaluating the association between psychological disorders
Figure 1. PRISMA Flow Diagram of Included Studies
7534 Records identified through
database searching
16 Additional records identified
through other sources
4662 Records excluded from
abstract and title screening
25 Excluded
11 Risk factors and/or rate missing
8 Ineligible data
6 Participants aged <18 y
33 Studies included in qualitative synthesis
33 Studies included in quantitative synthesis
(meta-analysis)
4720 Records after duplicates were removed
58 Full-text articles assessed for eligibility
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before surgery and prolonged opioid use after surgery, increased risks were observed among
participants with diagnoses of anxiety (OR, 1.14; 95% CI, 1.06-1.23), depression (OR, 1.54; 95% CI,
1.25-1.91), and mood disorders (OR, 1.85; 95% CI, 1.11-3.07). In contrast, patients with a diagnosis of
bipolar disorder before surgery had significantly lower risks for prolonged opioid use after surgery
(OR, 0.88; 95% CI, 0.79-0.98). Among pain conditions aggregated across all studies, prolonged
opioid use after surgery was most strongly associated with a history of back pain (OR, 2.05; 95% CI,
1.63-2.58) and fibromyalgia (OR, 1.43; 95% CI, 1.15-1.79) (Table 2).
Sensitivity and Additional Analyses
Our primary findings remained largely unchanged in leave-one-out analyses (eTable 4 in the
Supplement). No evidence of publication bias was found with the Egger regression-based test
(intercept, –20.99; 95% CI, –46.04% to 4.07%; SE, 12.28; P = .10) (eFigure in the Supplement).
Studies involving only opioid-naive participants before surgery had lower pooled rates of prolonged
opioid use after surgery (1.2%; 95% CI, 0.4%-3.9%). In the restricted analysis assessing chronic







–0.1–0.2 0.2 0.50.1 0.40.3
Event rate (95% CI)
0
Source Event rate (95% CI)
Bateman et al,16 2016 0.004 (0.003-0.004)
Bedard et al,49 2017 0.119 (0.116-0.121)
Bennett et al,30 2019 0.061 (0.057-0.066)
Brummett et al,12 2017 0.060 (0.058-0.063)
Carroll et al,55 2012 0.055 (0.025-0.117)
Clarke et al,46 2014 0.031 (0.030-0.033)
Connolly et al,48 2017 0.293 (0.284-0.303)
Fuzier et al,54 2018 0.050 (0.043-0.057)
Goesling et al,58 2016 0.122 (0.098-0.151)
Hadlandsmyth et al,69 2018 0.130 (0.122-0.138)
Hansen et al,67 2017 0.052 (0.049-0.056)
Inacio et al,68 2016 0.052 (0.047-0.056)
Johnson et al,31 2016 0.130 (0.127-0.133)
Kim et al,29 2017 0.074 (0.072-0.076)
Lindestrand et al,59 2015 0.300 (0.258-0.346)
Mulligan et al,60 2016 0.394 (0.314-0.480)
Namba et al,33 2018 0.304 (0.298-0.310)
Politzer et al,57 2018 0.191 (0.188-0.194)
Pugely et al,56 2018 0.237 (0.231-0.244)
Raebal et al,27 2014 0.040 (0.036-0.043)
Rao et al,61 2018 0.377 (0.362-0.391)
Rosenbloom et al,53 2017 0.352 (0.273-0.441)
Rozet et al,66 2014 0.297 (0.228-0.376)
Schoenfeld et al,50 2017 0.000 (0.000-0.001)
Shah et al,47 2017 0.001 (0.001-0.001)
Singh and Lewallen,62 2010 0.028 (0.023-0.035)
Singh and Lewallen,63 2012 0.014 (0.011-0.018)
Singh and Lewallen,64 2014 0.059 (0.045-0.077)
Sun et al,11 2016 0.003 (0.003-0.003)
Swenson et al,32 2018 0.005 (0.004-0.006)
Valdes et al,65 2015 0.252 (0.224-0.283)
Westermann et al,51 2017 0.192 (0.188-0.196)
Westermann et al,52 2019 0.151 (0.132-0.173)
Total 0.067 (0.045-0.098)
Squares indicate event rates, with horizontal lines
representing 95% CIs. The diamond represents the
pooled total, with the points of the diamond
representing 95% CIs. The data show substantial
between-study heterogeneity (P < .001; I2 = 99.96%).
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(95% CI) I2, % P value
Demographic characteristic
Age
≥50 y NA NA 1 [Reference] NA NA
<50 y 2 49, 56 1.83 (0.98-3.48) 98.71 <.001
Body mass indexa
<25 NA NA 1 [Reference] NA NA
25-29.9 4 62-64, 69 1.04 (0.52-2.10) 41.63 .16
30-34.9 3 62-64 1.21 (0.61-2.38) 38.58 .20
35-39.9 3 62-64 0.63 (0.31-1.30) 0 .54
≥40 3 62-64 0.98 (0.42-2.33) 17.52 .26
Sex
Male NA NA 1 [Reference] NA NA
Female 14 12, 31, 33, 46, 48, 49,
54, 57, 58, 61, 62, 65,
67, 69
1.16 (1.08-1.25) 88.87 <.001
Race/ethnicity
White NA NA 1 [Reference] NA NA
African American 7 12, 27, 32, 33, 47, 61,
69
1.02 (0.92-1.13) 69.35 .01
Asian 4 12, 33, 47, 61 0.68 (0.45-1.03) 91.25 <.001




NA NA 1 [Reference] NA NA
Less than high
school
2 12, 30 1.06 (0.56-2.00) 0 .91
High school 2 12, 30 1.20 (1.04-1.37) 0 .63
Some college 2 12, 30 1.10 (0.92-1.33) 49.41 .16
Preoperative
medication use
Antidepressants 6 11, 16, 27, 29, 46, 69 1.42 (1.11-1.81) 90.97 <.001
Antipsychotics 2 11, 16 1.15 (0.90-1.48) 0 .74
Benzodiazepines 5 11, 16, 29, 46, 69 1.53 (1.20-1.95) 91.72 <.001
Opioids 14 12, 27, 29, 32, 33, 51,
52, 56, 58-61, 66, 69
5.32 (2.94-9.64) 99.57 <.001
Substance use
Alcohol 8 11, 12, 29, 31, 47, 49,
53, 60
1.55 (1.07-2.25) 90.74 <.001
Cocaine 2 16, 29 4.34 (1.50-12.58) 0 .64
Marijuana 2 16, 29 0.89 (0.29-2.74) 0 .36
Tobacco 10 12, 16, 27, 29-31,
47-49, 60




Anxiety 9 12, 27, 30, 33, 53,
61-64
1.14 (1.06-1.23) 61.10 <.001
Bipolar disorders 2 33, 61 0.88 (0.79-0.98) 0 >.99
Depression 15 11, 32, 33, 47-49, 52,
53, 56, 61-64, 68, 71
1.54 (1.25-1.91) 97.90 <.001
Mood disorders 3 12, 30, 60 1.85 (1.11-3.07) 92.44 <.001
Psychiatric
disorders
5 11, 30, 51, 61, 68 1.04 (0.95-1.13) 0 .75
Posttraumatic
stress disorder
2 33, 61 1.39 (1.21-1.59) 0 .37
Unspecified mental
disorders
5 12, 30, 31, 33, 54 1.45 (0.78-2.68) 53.40 .07
(continued)
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opioid use,11,50,57,67-69,71 we observed a pooled rate of 2.3% (95% CI, 0.5%-10.6%). Similarly, in the 10
studies12,30,31,33,46,53,55,58,59,61 defining prolonged opioid use as the filling of at least 1 opioid
prescription within the first 90 days after surgery and the filling of at least 1 additional opioid
prescription from 91 to 180 days after surgery, the pooled rate was 13.8% (95% CI, 7.9%-23.0%). No
significant difference was observed in a comparison of major vs minor surgical procedures (pooled
rate, 7.0%; 95% CI, 4.9%-9.9% vs 11.1%; 95% CI, 6.0%-19.4%; (P = .20). Results from meta-analyses
of other study-level factors are presented in Table 3.
Discussion
This systematic review and meta-analysis of observational studies11,12,16,27,29-33,46-69 extend the
results of a previous meta-analysis73 reporting prolonged opioid use among approximately 1 in 10
individuals undergoing a major or minor surgical procedure. Our analyses indicated that
approximately 7% of patients filled opioid prescriptions at 3 months and more than 1 year after
surgery, a time beyond the normal postoperative recovery period.74 A higher rate was observed
when prolonged opioid use was defined as the filling of at least 1 prescription for opioids within 91 to
180 days after surgery. However, our primary pooled rate was attenuated when we restricted our
analyses to patients considered as opioid naive before surgery or to studies involving a more
conservative definition of prolonged use that is commonly used in the medical literature to
characterize chronic opioid use. Although these rates may appear to be relatively low, the negative
consequences that prolonged opioid use may impose on public health is perhaps better elucidated
when indexed to the number of surgical procedures performed annually in the US. In 2010,
approximately 51.4 million inpatient and 48.3 million ambulatory surgical procedures were estimated
to have been performed in the US.75,76 Based on previous studies77 reporting that 4 of 5 patients
undergoing surgery receive opioids, our pooled rate of 6.9%, when extrapolated to the total number





(95% CI) I2, % P value
Pain conditions
Arthritis 4 12, 30, 33, 61 1.19 (0.93-1.52) 94 <.001
Back pain 11 12, 16, 29, 33, 49, 51,
56, 61, 65, 67, 68
2.05 (1.63-2.58) 98.65 <.001
Chronic pain 5 27, 53, 60, 61, 69 1.35 (1.04-1.75) 85.92 <.001
Fibromyalgia 7 16, 29, 33, 49, 51, 56,
61
1.43 (1.15-1.79) 97.41 <.001
Migraine 4 16, 29, 61, 68 1.36 (1.02-1.80) 80.87 .01
Neck pain 4 12, 30, 33, 61 1.12 (1.02-1.23) 60.17 .06
Osteoarthritis 3 33, 54, 61 1.03 (0.96-1.09) 0 .47
Unspecified pain
disorders
9 12, 30-33, 54, 58, 61,
65
1.45 (1.21-1.72) 63.24 <.001
Other medical
conditions
Anemia 2 33, 61 1.06 (1.01-1.12) 0 .88
Coagulopathy 2 33, 61 1.20 (1.08-1.34) 0 .74
Cerebrovascular
disease
2 46, 47 0.90 (0.55-1.46) 34.07 .22
Diabetes 5 46, 54, 60, 61, 68 1.09 (0.90-1.31) 59.42 .04
Hypothyroidism 2 33, 61 0.99 (0.95-1.04) 0 .87
Liver disease 4 33, 47, 61, 68 1.23 (0.98-1.54) 87.56 .005
Obesity 2 48, 65 1.25 (0.67-2.35) 87.56 .005
Pulmonary disease 4 48, 65 1.32 (1.07-1.63) 92.55 <.001
Renal disease 3 33, 46, 61 1.02 (0.97-1.08) 0 .40
Substance abuse 11 11, 16, 27, 29, 31, 33,
49, 53, 56, 61, 69
1.58 (1.14-2.21) 98.47 <.001
Abbreviations: NA, not applicable; OR, odds ratio.
a Calculated as weight in kilograms divided by height
in meters squared.
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of surgical procedures, implies that up to 5.7 million Americans may potentially become persistent
opioid users annually after surgery. Of note, individuals with prolonged opioid use after surgery
constitute a group with potentially significant risk of chronic use. Therefore, prioritizing strategies
that mitigate the transition of patients undergoing surgery to persistent opioid use while still
optimizing the management of postoperative pain is of importance.
A possible approach to reducing the burden of prolonged opioid use is to characterize the
underlying mechanisms, including patient-level risk factors, that may be associated with prolonged
and/or chronic use of opioids after surgery. This approach, in part, rests on the assumption that
patient-level risk factors associated with prolonged opioid use may be modifiable and can be used in
screening for at-risk individuals.74 Our results indicate that preoperative exposure to medications,
such as opioids, antidepressants, benzodiazepines, or cocaine; demographic factors, such as sex; and
presence of medical comorbidities, including chronic pain, back pain, substance abuse, mood
disorders, or depression before surgery, had some of the strongest associations with prolonged
opioid use after surgery. Congruent with previous reviews,73,78 the strongest association in the
current study was observed with preoperative opioid use, wherein individuals who had filled at least
1 opioid prescription in the year before surgery had a 5.3-fold risk of prolonged opioid use after
surgery (pooled OR, 5.32; 95% CI, 2.94-9.64). These findings of increased risk of preoperative opioid
use and prolonged use after surgery was further corroborated when we restricted our analyses to
studies enrolling opioid-naive participants at baseline; the pooled rate of prolonged opioid use after
Table 3. Random-Effects Pooled Rates From Additional Analyses
Characteristic Studies, No. Participants, No. References Pooled rate (95% CI) P value I2, % P value
Country of patient enrollment





Non-US 7 68 737 46, 53, 54, 59, 65, 67, 68 10.7 (6.2-18.1) 99.56 <.001
Length of follow-up, mo





≤6 11 207 148 12, 30-32, 46, 51, 53, 55, 58, 59, 66 9.6 (6.2-14.6) 99.86 <.001









Hospital institution data 12 713 818 33, 47, 53, 55, 58, 59, 61-65, 72 9.8 (2.5-31.5) 99.95 <.001
Military insurance
beneficiaries
5 41 334 50, 66-69 5.4 (2.9-9.8) 99.36 <.001
National insurance plans 2 42 805 46, 54 3.9 (2.5-6.2) 97.18 <.001
Major vs minor surgery





Minor surgery 4 16 275 30, 52, 54, 66 11.1 (6.0-19.4) 98.75 <.001
Orthopedic vs nonorthopedic
surgery
Orthopedic 23 399 248 29, 31, 33, 48-54, 56-60, 62-69 12.1 (9.7-14.9) .07 99.84 <.001




8 902 689 11, 12, 30-32, 46, 50 1.2 (0.4-3.9) NA 99.97 <.001
Similar definitions for chronic
opioid use after surgerya
7 760 723 11, 27, 50, 57, 67-69 2.3 (0.5-1.6) NA 99.98 <.001
Similar definitions for
prolonged opioid use after
surgeryb
10 175 486 12, 30, 31, 33, 46, 53, 55, 58, 59, 61 13.8 (7.9-23.0) NA 99.93 <.001
Abbreviation: NA, not applicable.
a Included studies defining opioid use after surgery as the receipt of opioids for 10 opioid
fills or more, 90 or more consecutive days’ supply of opioids, or 120 cumulative days
in the first year after surgery after excluding the first 90 postoperative days.
b Included studies defining prolonged opioid use as 1 opioid fill or more within 91 to 180
days after surgery.
JAMA Network Open | Surgery Rate and Risk Factors Associated With Prolonged Opioid Use After Surgery
JAMA Network Open. 2020;3(6):e207367. doi:10.1001/jamanetworkopen.2020.7367 (Reprinted) June 25, 2020 13/19
Downloaded From: https://jamanetwork.com/ by a University of Rhode Island User  on 07/17/2020
surgery decreased more than 5-fold. Appropriate prescribing of the dose and quantity of opioids
after surgery, the evaluation of opioid use in patients before surgery, and attempts to modify patient-
level risk factors when possible or to treat underlying medical conditions before surgery may be
included as part of a comprehensive strategy to reduce prolonged opioid use after surgery.
Multimodal analgesia, psychobehavioral management of pain, and regional and neuraxial anesthesia
have also been listed in the literature78-80 as strategies associated with reducing the transition to
prolonged opioid use after surgery.
Although our analyses suggest that surgery may be associated with long-term opioid use, it is
possible that the observed association was enhanced by confounding from an underlying chronic
pain condition, the developing of persistent postsurgical pain, or surgical procedures exacerbating
preexisting conditions and thus warranting long-term opioid management. Persistent postsurgical
pain is a recognized complication of surgery and has been reported after common surgical
procedures, including cesarean delivery or hip replacement.38,81 Several studies38,81-84 suggest that
between 20% and 60% of individuals who undergo surgical procedures may transition from acute
to persistent or chronic postsurgical pain. Because opioids were considered the standard of care for
chronic noncancer pain management for studies included in this meta-analysis,2,10 the findings
suggest that a high rate of prolonged opioid use after surgery may reflect the expected opioid use
patterns among individuals with persistent postsurgical pain or underlying chronic pain. Because of a
lack of information in the included studies, we were unable to assess the association between these
confounding factors and opioid use after surgery in our analyses.
Of note, other mechanisms not associated with surgical pain before or after undergoing the
procedure could have explained the findings of increased prolonged opioid use with surgery.
Because major surgical procedures are likely to be associated with higher frequencies or intensities
of postoperative pain and perhaps with a longer recovery time compared with minor surgical
procedures, we expected significant differences in the pooled rate of prolonged opioid use in major
vs minor surgical procedures. However, we found no such evidence in our subgroup analysis.
Although a similar finding was recently reported in a large retrospective study of US adults
undergoing minor or major surgical procedures,12 a meta-analysis by Mohamadi et al72 reported
significant differences in prolonged opioid use between these categories of procedures. Therefore,
further research should aim to delineate the causal mechanisms of continuous use of opioids in the
postoperative period, particularly in the context of surgical pain.
Limitations
This study has limitations. Because the studies included in our analyses were observational by design,
our findings may be prone to several forms of systematic bias, including selection bias and
measurement errors. Of importance, our findings may have been subject to confounding by the
underlying indication and inadequate bias adjustment. Second, although we performed several
sensitivity analyses to explore the sources of heterogeneity, we were unable to explain the
substantial heterogeneity present in most of our analyses. We used a random-effects model for our
analyses, with the a priori assumption that the included studies would be heterogenous in their
design, sample size, definitions of prolonged opioid use and risk factors, and adjustment of
covariates. Third, because of a paucity of eligible studies and suboptimal reporting, we were unable
to exclude studies involving participants with chronic opioid use at baseline, participants with
preexisting pain disorders, or participants with a diagnosis of cancer before surgery—conditions that
are frequently managed with opioids. Of note, the inclusion of these individuals may have led to an
overestimation in the magnitude of prolonged opioid use after surgery.85 In addition, although less
likely to be substantial, it is unknown the extent to which some of the eligibility criteria (eg, requiring
studies to have reported the rate and risk factors for prolonged use) or not contacting authors may
have affected the magnitude of observed association.
Despite these limitations, confidence in our findings is perhaps reinforced because of the
absence of small-study bias and consistent results from study-level factors that might have
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moderated our observed association. Nevertheless, further research is needed to quantify the effect
of these various sources of bias on our study findings.
Conclusions
In this study, preoperative use of opioids and cocaine and the presence of comorbid pain conditions
before surgery had the strongest associations with prolonged opioid use after surgery. These largely
modifiable patient-level risk factors may be included as part of a comprehensive strategy to screen
for at-risk individuals requiring transition to nonopioid interventions after surgery while ensuring
appropriate short-term opioid use to manage postoperative pain. Research is needed to further
investigate the association between surgical pain and prolonged opioid use after surgery.
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